• Back to miR-5100

• Dong L, Li Y, Han C, Wang X, She L, Zhang H. miRNA microarray reveals specificexpression in the peripheral blood of glioblastoma patients. Int J Oncol. 2014Aug;45(2):746-56. doi: 10.3892/ijo.2014.2459. Epub 2014 May 22. PubMed PMID:24858071. See more on PubMed
• Huang H, Jiang Y, Wang Y, Chen T, Yang L, He H, Lin Z, Liu T, Yang T, Kamp DW,Wu B, Liu G. miR-5100 promotes tumor growth in lung cancer by targeting Rab6.Cancer Lett. 2015 Jun 28;362(1):15-24. doi: 10.1016/j.canlet.2015.03.004. Epub2015 Mar 6. PubMed PMID: 25754817. See more on PubMed
• Chijiiwa Y, Moriyama T, Ohuchida K, Nabae T, Ohtsuka T, Miyasaka Y, Fujita H, Maeyama R, Manabe T, Abe A, Mizuuchi Y, Oda Y, Mizumoto K, Nakamura M.Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. Int J Oncol. 2016 Apr;48(4):1688-700. doi:10.3892/ijo.2016.3389. Epub 2016 Feb 12. PubMed PMID: 26892887. See more on PubMed
• Li CY, Wang YH, Lin ZY, Yang LW, Gao SL, Liu T, Zou BA, Pan ZC, Song ZQ, LiuG. MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associatedwith activating smad2/3 in lung epithelial cells. Am J Transl Res. 2017 Oct15;9(10):4694-4706. eCollection 2017. PubMed PMID: 29118928; PubMed CentralPMCID: PMC5666075. See more on PubMed
• Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 arePromising Prognosis Predictors for Oral Squamous Cell Carcinoma. Theranostics.2019 Jan 25;9(4):920-931. doi: 10.7150/thno.30339. eCollection 2019. PubMed PMID:30867806; PubMed Central PMCID: PMC6401397. See more on PubMed
• Sun X, Wang M, Liu H, Wang J. MicroRNA-423 enhances the invasiveness ofhepatocellular carcinoma via regulation of BRMS1. Am J Transl Res. 2017 Dec15;9(12):5576-5584. eCollection 2017. PubMed PMID: 29312509; PubMed CentralPMCID: PMC5752907. See more on PubMed
• Wang H, Cui Y, Luan J, Zhou X, Li C, Li H, Shi L, Han J. MiR-5100 promotesosteogenic differentiation by targeting Tob2. J Bone Miner Metab. 2017Nov;35(6):608-615. doi: 10.1007/s00774-016-0799-y. Epub 2016 Nov 21. PubMed PMID:27873073. See more on PubMed
• Wang T, Liu X, Tian Q, Liang T, Chang P. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis. Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3592-3597. PubMed PMID: 28925485. See more on PubMed
• Yang L, Lin Z, Wang Y, Gao S, Li Q, Li C, Xu W, Chen J, Liu T, Song Z, Liu G. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells byinhibiting the Rab6. Mol Carcinog. 2018 Mar;57(3):419-428. doi: 10.1002/mc.22765.Epub 2017 Dec 1. PubMed PMID: 29144562. See more on PubMed
• Yuan DM, Wu SY, Huang SL, Jiang WC, Ke YB. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia]. Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Sep 10;38(9):1252-1258. doi:10.3760/cma.j.issn.0254-6450.2017.09.022. Chinese. PubMed PMID: 28910942. See more on PubMed
• Zeng L, Wu JL, Liu LM, Jiang JQ, Wu HJ, Zhao M, Lu QJ. Serum miRNA-371b-5p andmiRNA-5100 act as biomarkers for systemic lupus erythematosus. Clin Immunol. 2018Nov;196:103-109. doi: 10.1016/j.clim.2018.10.004. Epub 2018 Oct 7. PubMed PMID:30304699. See more on PubMed